Phase i dose-escalation study of vb-111, an antiangiogenic virotherapy, in patients with advanced solid tumors
View/ Open
Full Text
Date
2013-04-15Author
Brenner, A. J.
Cohen, Y. C.
Breitbart, E.
Bangio, L.
Sarantopoulos, J.
Giles, F. J.
Borden, E. C.
Harats, D.
Triozzi, P. L.
Metadata
Show full item recordUsage
This item's downloads: 0 (view details)
Cited 11 times in Scopus (view citations)
Recommended Citation
Brenner, A. J. Cohen, Y. C.; Breitbart, E.; Bangio, L.; Sarantopoulos, J.; Giles, F. J.; Borden, E. C.; Harats, D.; Triozzi, P. L. (2013). Phase i dose-escalation study of vb-111, an antiangiogenic virotherapy, in patients with advanced solid tumors. Clinical Cancer Research 19 (14), 3996-4007